Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPEED
NCT07090824Phase 1Completed
- Sponsor
- Stanford University
- Start
- Oct 2025
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Stanford University. Primary endpoints: Time to Maximum Insulin Concentration, Maximum Plasma Insulin Concentration and 2 more. Started Oct 2025; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07090824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07090824.